NorthRock Partners LLC Trims Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

NorthRock Partners LLC lowered its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 29.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,755 shares of the company’s stock after selling 1,145 shares during the period. NorthRock Partners LLC’s holdings in GE HealthCare Technologies were worth $259,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the business. Arthur M. Cohen & Associates LLC bought a new stake in GE HealthCare Technologies during the third quarter worth about $208,000. Amalgamated Bank boosted its stake in GE HealthCare Technologies by 2.1% during the third quarter. Amalgamated Bank now owns 87,175 shares of the company’s stock worth $8,181,000 after acquiring an additional 1,757 shares in the last quarter. Hazlett Burt & Watson Inc. lifted its stake in shares of GE HealthCare Technologies by 779.3% in the third quarter. Hazlett Burt & Watson Inc. now owns 721 shares of the company’s stock worth $67,000 after buying an additional 639 shares in the last quarter. QRG Capital Management Inc. lifted its stake in shares of GE HealthCare Technologies by 7.3% in the third quarter. QRG Capital Management Inc. now owns 7,128 shares of the company’s stock worth $669,000 after buying an additional 485 shares in the last quarter. Finally, Asset Management One Co. Ltd. lifted its stake in shares of GE HealthCare Technologies by 0.9% in the third quarter. Asset Management One Co. Ltd. now owns 164,750 shares of the company’s stock worth $15,462,000 after buying an additional 1,507 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at approximately $2,101,291.04. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 0.27% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

GEHC has been the topic of several research reports. Evercore ISI raised their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. Stifel Nicolaus raised their target price on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a report on Monday, September 30th. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a research report on Wednesday, September 18th. Finally, Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $94.36.

GE HealthCare Technologies Stock Down 1.6 %

Shares of GEHC stock opened at $86.78 on Thursday. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The company has a market capitalization of $39.65 billion, a price-to-earnings ratio of 23.84, a PEG ratio of 3.12 and a beta of 1.24. The company’s fifty day moving average price is $88.74 and its 200-day moving average price is $83.46. GE HealthCare Technologies Inc. has a one year low of $66.39 and a one year high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.06 by $0.08. The company had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. GE HealthCare Technologies’s revenue for the quarter was up .9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.99 EPS. Sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.29 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.03 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is currently 3.30%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.